about
Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineGrowth hormone tumor histological subtypes predict response to surgical and medical therapy.Surgical treatment of microprolactinomas: pros.Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.Pasireotide for the treatment of acromegaly.Current and future medical treatments for patients with acromegaly.Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas.Cabergoline in acromegaly.Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.Experience with pegvisomant treatment in acromegaly in a single Brazilian tertiary reference center: efficacy, safety and predictors of response.
P2860
Q34277844-7B6662C0-AC7F-4C76-B56D-90CC1F33AC2DQ35091578-5414D0AD-2DA1-4C21-B2A4-2381B466318BQ38211820-F561C770-FD41-405B-9354-54B887A8BA61Q38233686-28F4A2C1-899E-47C1-950B-25C43E708CC3Q38710873-3E57B51D-B90A-44AA-A71B-78AE2BFCF135Q38847622-DEB09247-9A13-43C1-A5A8-845E5A3C0F34Q39024218-60796310-9C32-407D-BA45-C7DB3E16424CQ39057164-D9468CD6-8984-4064-929A-9D1817E6AD98Q39064562-46BDFF61-8C59-4AB2-90C9-08EFFF112FEFQ39294965-D5E96F5D-39A6-4291-824F-7B730C1713DA
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Cabergoline treatment in acromegaly: cons.
@en
Cabergoline treatment in acromegaly: cons.
@nl
type
label
Cabergoline treatment in acromegaly: cons.
@en
Cabergoline treatment in acromegaly: cons.
@nl
prefLabel
Cabergoline treatment in acromegaly: cons.
@en
Cabergoline treatment in acromegaly: cons.
@nl
P2860
P1433
P1476
Cabergoline treatment in acromegaly: cons.
@en
P2093
Leandro Kasuki
Mônica R Gadelha
P2860
P2888
P304
P356
10.1007/S12020-014-0183-4
P577
2014-02-07T00:00:00Z
P5875
P6179
1005978659